Latest news
Loading news…
ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Barcelona, Catalonia, Spain
Key People at ADmit Therapeutics
Co-Founder and Chief Scientific Officer
Co-Founder and CEO
Co-Founder and Chief Medical Officer
4
professional contacts at ADmit Therapeutics
Contact execs at ADmit Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ADmit Therapeutics
Loading news…
FAQs about ADmit Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.